Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<table style="background: cellspacing="5px" cellpadding="10px" width="100%"> | <table style="background: cellspacing="5px" cellpadding="10px" width="100%"> | ||
<tr> | <tr> | ||
| - | <td style="width: | + | <td style="width:25%;border-width:1px; border-style:inset; background:#F1F2FC"> |
<div style="font-size:150%; line-height:1.0em; text-align:center">[[Cancer]]</div> | <div style="font-size:150%; line-height:1.0em; text-align:center">[[Cancer]]</div> | ||
</td> | </td> | ||
| - | <td style="width: | + | <td style="width:24%;border-width:1px; border-style:inset; background:#F1F2FC"> |
<div style="font-size:150%; line-height:1.0em; text-align:center">[[Diabetes]]</div> | <div style="font-size:150%; line-height:1.0em; text-align:center">[[Diabetes]]</div> | ||
</td> | </td> | ||
| - | <td style="width: | + | <td style="width:25%;border-width:1px; border-style:inset; background:#F1F2FC"> |
<div style="font-size:150%; line-height:1.0em; text-align:center">[[Hypercholesterolemia]]</div> | <div style="font-size:150%; line-height:1.0em; text-align:center">[[Hypercholesterolemia]]</div> | ||
| + | </td> | ||
| + | <td style="width:25%;border-width:1px; border-style:inset; background:#F1F2FC"> | ||
| + | <div style="font-size:150%; line-height:1.0em; text-align:center">[[Hypertension]]</div> | ||
</td> | </td> | ||
<tr> | <tr> | ||
| - | <td style="width: | + | <td style="width:25%; vertical-align:top;border-width:1px; border-style:inset"> |
* [[EGFR]] Inhibitor | * [[EGFR]] Inhibitor | ||
** [[Iressa]] - Generic: Gefitinib | ** [[Iressa]] - Generic: Gefitinib | ||
** [[Tarceva]] - Generic: Erlotinib | ** [[Tarceva]] - Generic: Erlotinib | ||
</td> | </td> | ||
| - | <td style="width: | + | <td style="width:24%; vertical-align:top;border-width:1px; border-style:inset"> |
* [[PPAR]] Agonists | * [[PPAR]] Agonists | ||
** [[Actos]] - Generic: Pioglitazone | ** [[Actos]] - Generic: Pioglitazone | ||
** [[Avandia]] - Generic: Rosiglitazone | ** [[Avandia]] - Generic: Rosiglitazone | ||
</td> | </td> | ||
| - | <td style="width: | + | <td style="width:25%; vertical-align:top;border-width:1px; border-style:inset"> |
* [[HMGR]] Inhibitors (Statins) | * [[HMGR]] Inhibitors (Statins) | ||
** [[Baycol]] - Generic: Cerivastatin | ** [[Baycol]] - Generic: Cerivastatin | ||
| Line 29: | Line 32: | ||
** [[Mevacor]] - Generic: Lovastatin | ** [[Mevacor]] - Generic: Lovastatin | ||
** [[Zocor]] - Generic: Simvastatin | ** [[Zocor]] - Generic: Simvastatin | ||
| + | </td> | ||
| + | <td style="width:25%; vertical-align:top;border-width:1px; border-style:inset"> | ||
| + | [[ACE]] Inhibitors | ||
| + | * [[Aceon]] - Generic: Perindopril | ||
| + | * [[Altace]] - Generic: Ramipril | ||
| + | * [[Capoten]] - Generic: Captopril | ||
| + | * [[Lotensin]] - Generic: Benazepril | ||
| + | * [[Mavik]] - Generic: Trandolapril | ||
| + | * [[Prinivil]] - Generic: Lisinopril | ||
| + | * [[Vasotec]] - Generic: Enalapril | ||
</td> | </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
| - | <td style="width: | + | <td style="width:25%;border-width:1px; border-style:inset; background:#F1F2FC"> |
| - | <div style="font-size:150%; line-height:1.0em; text-align:center"> | + | <div style="font-size:150%; line-height:1.0em; text-align:center">--</div> |
</td> | </td> | ||
| - | <td style="width: | + | <td style="width:24%;border-width:1px; border-style:inset; background:#F1F2FC"> |
<div style="font-size:150%; line-height:1.0em; text-align:center">--</div> | <div style="font-size:150%; line-height:1.0em; text-align:center">--</div> | ||
</td> | </td> | ||
| - | <td style="width: | + | <td style="width:25%;border-width:1px; border-style:inset; background:#F1F2FC"> |
| + | <div style="font-size:150%; line-height:1.0em; text-align:center">--</div> | ||
| + | </td> | ||
| + | <td style="width:25%;border-width:1px; border-style:inset; background:#F1F2FC"> | ||
<div style="font-size:150%; line-height:1.0em; text-align:center">--</div> | <div style="font-size:150%; line-height:1.0em; text-align:center">--</div> | ||
</td> | </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
| - | <td style="width: | + | <td style="width:25%; vertical-align:top;border-width:1px; border-style:inset"> |
| - | + | </td> | |
| - | + | <td style="width:24%; vertical-align:top;border-width:1px; border-style:inset"> | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
</td> | </td> | ||
| - | <td style="width: | + | <td style="width:25%; vertical-align:top;border-width:1px; border-style:inset"> |
</td> | </td> | ||
| - | <td style="width: | + | <td style="width:25%; vertical-align:top;border-width:1px; border-style:inset"> |
</td> | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
Revision as of 19:02, 29 November 2010
|
ACE Inhibitors |
|||
|
--
|
--
|
--
|
--
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
